Pasithea Therapeutics Corp
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
33.4M
on 2026-06-30, from 1.04M on 2024-03-31 10-Q ↗
a raise that quarter, at its price
Newest
S-3 of 2024-10-07. Not read yet. S-3 ↗
$4.2M
Agreement of 2024-11-26. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗
Cash
10.3 quarters
$45.7M on 2026-06-30 ÷ $4.4M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2025-11-28 | Public offering incl. 65.15M pre-funded | 80,000,000 | $0.75 | $59.9M | 424B4 ↗ |
| 2025-11-28 | Private placement incl. 65.15M pre-funded | 80,000,000 | not read | $60.0M | 8-K ↗ |
| 2025-05-06 | Public offering incl. 0.48M pre-funded, with warrants at $1.40 | 3,571,428 | $1.40 | $5.0M | 424B4 ↗ |
| 2025-05-06 | Private placement incl. 0.48M pre-funded | 3,571,428 | not read | $1.3M | 8-K ↗ |